 Continuous subcutaneous insulin infusion CSII multiple injections MI conventional insulin therapy CT self-selecting insulin-dependent diabetic patients comparison metabolic control acute complications patient preferences Continuous subcutaneous insulin infusion CSII multiple injections MI metabolic advantages highly-selected insulin-dependent diabetics IDDs comparative studies self-selected IDDs MI optimal insulin preparation overnight insulin delivery conventional injection therapy CT CSII MI human isophane insulin MI/human isophane human ultralente insulin MI/human ultralente bedtime self-selected IDDs IDDs individuals study indices glycaemic control values CSII MI CT differences small blood glucose MI/human ultralente MI/human isophane subcutaneous abscess case ketoacidosis hospitalization CSII Serious hypoglycaemic episodes intensified therapy patients intensified insulin therapy half CSII